*Breakfast to be served from 6:00am*

Learning Objectives: 

At the end of this session, participants will be able to: 

• Outline the role of the Tie-2/ang pathway in DR and nAMD
  and how it may impact patient outcomes
• Identify the most important biomarkers
  on structural OCT that can help predict treatment
  response in DME and nAMD
• Discuss real-world case presentations and when
  to switch patients from one agent to another
• Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER)

CanMEDS Roles: Medical expert, scholar